Compensation Limit

The Compensation Limit, in the context of employer-sponsored 401(k) plans, refers to the maximum amount of an employee's compensation that can be considered for retirement plan contributions and calculations during a given tax year. This limit is imposed by the Internal Revenue Service (IRS) to ensure fairness and prevent high-income earners from benefiting disproportionately from the tax advantages of 401(k) plans.

Examples:

  • Contribution Cap: Suppose an employee earns $300,000 in a tax year, and the IRS sets the Compensation Limit at $290,000. If the employee contributes a percentage of their salary to the 401(k) plan, they can only base their contributions on the $290,000 Compensation Limit, regardless of their actual income.

  • Employer Match: A company may offer a generous 401(k) matching program, stating that they will match 50% of an employee's contributions up to the Compensation Limit. If an employee earns $80,000 and contributes $12,000 to their 401(k), the employer's matching contribution will be $6,000 (50% of the Compensation Limit), even if the employee's total earnings exceed the Compensation Limit.

  • Highly Compensated Employees (HCEs): The Compensation Limit plays a crucial role in the determination of highly compensated employees. To maintain the plan's qualified status, the contributions made by HCEs cannot disproportionately skew the plan in favor of top earners. The Compensation Limit helps regulate HCEs' contributions to ensure compliance with IRS regulations.

Understanding the Compensation Limit is vital for employers and employees alike, as it influences the maximum allowable contributions and ensures that the 401(k) plan remains in compliance with tax regulations. Employers must keep track of the Compensation Limit each year to administer the retirement plan accurately and provide equitable benefits to all employees.

Next Up

According to Mployer Insights’ 2026 analysis of 76,000+ employer benefit plans, disability insurance remains a major market differentiator, with only 41% of U.S. employers offering short-term disability (STD) and 38% offering long-term disability (LTD). While 60% salary replacement serves as the national standard across both benefit types, standard plan designs disproportionately expose higher earners due to median benefit caps of $1,602/week for STD and $8,273/month for LTD. Furthermore, alignment between STD benefit durations (median 26 weeks) and LTD elimination periods (68% at 90 days) remains a critical area for plan structure optimization.
Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.